In this section
There are many organisations both nationally and internationally who are providing CF specific information about COVID-19. We recommend Australian resources as these are most relevant to our local situation. We strongly encourage you to visit the State or Federal services website for up-to-date information:
Physical exercise programs whilst in quarantine can be a tricky task. Our respiratory physiotherapy team have prepared a handout that lists a range of exercise resources split into age appropriate categories including online videos and virtual exercise platforms. This is beneficial for all patients (and parents) not just patients with CF/bronchiectasis/PCD. Download the resource
Chest exacerbations are often caused by viral infections and this might include the virus that causes COVID-19.
For children with cystic fibrosis:
To download a higher resolution PDF, click
For children with PCD and non-CF bronchiectasis:
If you or your child notices a change in their baseline cough:
Reassess your child’s cough after two weeks:
If at any point your child becomes more unwell:
For situations requiring urgent medical review:
Our department is organising home cough swabs and sputum samples to those who require it. In this circumstance the department will send instructions and equipment to families prior to clinic.
Lung function testing is only available for urgent/clinically indicated cases. This is due to the risk of lung function tests aerosolising virus particles, risking infection of other patients and staff.
Please see our page on clinical processes on how to organise scripts through the department.
Most children who contract COVID-19 will suffer only mild symptoms. If your child develops new respiratory symptoms such as fever, cough, runny nose, increased secretions or sore throat, continue with your child’s usual respiratory management and contact your RCH team (Complex care hub or respiratory teams – see ‘Getting in touch' for further advice if you have concerns.
If your child has a respiratory tract infection, tracheostomies can increase the risk of spreading the viruses through dispersing moisture droplets carrying the virus in the air (aerosols). Parents can take measures to reduce the risk of infection to others in the household, including getting vaccinated if eligible, good hand hygiene, the main carer wearing a surgical mask
(see the FAQ for more advice around reducing infection spread).
Should a face-to-face review be required, this will be coordinated through the emergency department rather than the outpatient department given the risk of virus aerosolization through a tracheostomy.
Compared to adults, most children infected with coronavirus (COVID-19) have a milder illness.
Continuing to use CPAP or BIPAP during respiratory tract infection depends on your child’s device and how dependent they are on it. You may need to discuss your child’s specific needs with your treating physician, however:
Manufacturer guidelines should be followed regarding cleaning/disinfection of mask and tubing.
Clinic reviews will be coordinated predominantly through telehealth appointments. Face-to-face appointments will only be organised at the discretion of your clinician. If a face-to-face review be required, this will be coordinated through the outpatient department. For patients who are on day time ventilation, face-to-face reviews may be coordinated through the emergency department rather than the outpatient department given the risk of virus aerosolization from the ventilation.
Home overnight oximetry testing is available.
There may be delays and these studies will be prioritised based on urgency.
Most research activities will be put on hold. This may change overtime and the relevant families will be contacted when this occurs.
For AREST CF study participants aged 0–2 years can you:
AREST CF Part 3: The Next Generation of Impact in Cystic Fibrosis